Fig. 6.
Fig. 6. Reversion of the amifostine antiapoptotic effect in CD34+ cells by the κB decoy oligonucleotide. CD34+ cells (purity, >96%, ≤98%; 105/mL) were incubated in 10% FCS-RPMI, with or without a cytokine mix (see Materials and Methods), amifostine (8 μg/mL), decoy, or scrambled oligo (5 μmol/L) for 16 hours. Apoptosis was then analyzed by propidium iodide incorporation in cell DNA. The results represent the means ± SE of 4 separate experiments.

Reversion of the amifostine antiapoptotic effect in CD34+ cells by the κB decoy oligonucleotide. CD34+ cells (purity, >96%, ≤98%; 105/mL) were incubated in 10% FCS-RPMI, with or without a cytokine mix (see Materials and Methods), amifostine (8 μg/mL), decoy, or scrambled oligo (5 μmol/L) for 16 hours. Apoptosis was then analyzed by propidium iodide incorporation in cell DNA. The results represent the means ± SE of 4 separate experiments.

Close Modal

or Create an Account

Close Modal
Close Modal